Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy

被引：0
|
作者：
Diane Libert
Constance M. Yuan
Katherine E. Masih
Pallavi Galera
Dalia Salem
Haneen Shalabi
Bonnie Yates
Cindy Delbrook
Jack F. Shern
Terry J. Fry
Javed Khan
Maryalice Stetler-Stevenson
Nirali N. Shah
机构：
[1] National Cancer Institute (NCI),Pediatric Oncology Branch, Center for Cancer Research (CCR)
[2] NIH,Laboratory of Pathology, CCR
[3] NCI,Oncogenomics Section, Genetics Branch
[4] NIH,Division of Human Immunology and Immunotherapy Initiative, Pediatric Hematology/Oncology
[5] CCR,undefined
[6] NCI,undefined
[7] NIH,undefined
[8] Children’s Hospital of Colorado,undefined
来源：
Leukemia | 2020年 / 34卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3064 / 3069
页数：5
相关论文
共 50 条
  • [1] Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy
    Libert, Diane
    Yuan, Constance M.
    Masih, Katherine E.
    Galera, Pallavi
    Salem, Dalia
    Shalabi, Haneen
    Yates, Bonnie
    Delbrook, Cindy
    Shern, Jack F.
    Fry, Terry J.
    Khan, Javed
    Stetler-Stevenson, Maryalice
    Shah, Nirali N.
    [J]. LEUKEMIA, 2020, 34 (11) : 3064 - 3069
  • [2] Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts
    Chen, Dong
    Fuda, Franklin
    Rosado, Flavia
    Saumell, Silvia
    John, Samuel
    Chen, Mingyi
    Koduru, Prasad
    Chen, Weina
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (03) : 503 - 509
  • [3] Clinicopathologic Features of Relapsed CD19(-) B-ALL in CD19-Targeted Immunotherapy: Insights Into Mechanism of Relapse and LILRB1 as a Novel B-cell Marker for CD19(-) B Lymphoblasts
    Chen, Dong
    Fuda, Franklin
    Rosado, Flavia
    Saumell, Silvia
    John, Samuel
    Koduru, Prasad
    Chen, Weina
    [J]. LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 930 - 930
  • [4] Clinicopathologic Features of Relapsed CD19(-) B-ALL in CD19-Targeted Immunotherapy: Insights Into Mechanism of Relapse and LILRB1 as a Novel B-cell Marker for CD19(-) B Lymphoblasts
    Chen, Dong
    Fuda, Franklin
    Rosado, Flavia
    Saumell, Silvia
    John, Samuel
    Koduru, Prasad
    Chen, Weina
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 930 - 930
  • [5] Loss of CD19 expression in B-cell neoplasms
    Masir, N
    Marafioti, T
    Jones, M
    Natkunam, Y
    Rüdiger, T
    Hansmann, ML
    Mason, DY
    [J]. HISTOPATHOLOGY, 2006, 48 (03) : 239 - 246
  • [6] CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
    Gambella, Massimiliano
    Carlomagno, Simona
    Raiola, Anna Maria
    Giannoni, Livia
    Ghiggi, Chiara
    Setti, Chiara
    Giordano, Chiara
    Luchetti, Silvia
    Serio, Alberto
    Bo, Alessandra
    Falco, Michela
    Della Chiesa, Mariella
    Angelucci, Emanuele
    Sivori, Simona
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Diminished expression of CD19 in B-cell lymphomas
    Wei, Y
    Agrawal, N
    Patel, J
    Edinger, A
    Osei, E
    Thut, D
    Powers, J
    Meyerson, H
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 63B (01) : 28 - 35
  • [8] A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
    Cardarelli, Pina M.
    Rao-Naik, Chetana
    Chen, Sharline
    Huang, Haichun
    Pham, Amie
    Moldovan-Loomis, Maria-Cristina
    Pan, Chin
    Preston, Ben
    Passmore, David
    Liu, Jie
    Kuhne, Michelle R.
    Witte, Alison
    Blanset, Diann
    King, David J.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (02) : 257 - 265
  • [9] A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
    Pina M. Cardarelli
    Chetana Rao-Naik
    Sharline Chen
    Haichun Huang
    Amie Pham
    Maria-Cristina Moldovan-Loomis
    Chin Pan
    Ben Preston
    David Passmore
    Jie Liu
    Michelle R. Kuhne
    Alison Witte
    Diann Blanset
    David J. King
    [J]. Cancer Immunology, Immunotherapy, 2010, 59 : 257 - 265
  • [10] CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients
    Sonanini, Dominik
    Schwenck, Johannes
    Blaess, Simone
    Schmitt, Julia
    Maurer, Andreas
    Ehrlichmann, Walter
    Ritter, Malte
    Skokowa, Julia
    Kneilling, Manfred
    Jung, Gundram
    Fend, Falko
    Krost, Simon
    Seitz, Christian M.
    Lang, Peter
    Reischl, Gerald
    Handgretinger, Rupert
    Fougere, Christian la
    Pichler, Bernd J.
    [J]. BIOMARKER RESEARCH, 2024, 12 (01)
12345